ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,418Medicare Part D Prescriptions Filled, Including Refills
$503K Total Retail Price of All Prescriptions
484 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 481 329
AMLODIPINE BESYLATE 333 260
LISINOPRIL 304 236
WARFARIN SODIUM 301 260
LEVOTHYROXINE SODIUM 277 190
OMEPRAZOLE 269 197
METOPROLOL TARTRATE 235 219
HYDROCODONE-ACETAMINOPHEN 227 179 S3
POTASSIUM CHLORIDE 217 163
ATORVASTATIN CALCIUM 212 156
METFORMIN HCL 195 141
FUROSEMIDE 185 159
TRAMADOL HCL 173 109
ZETIA 149 120
SERTRALINE HCL 147 119
GABAPENTIN 144 108
METOPROLOL SUCCINATE 144 135
DONEPEZIL HCL 136 117
CITALOPRAM HBR 126 97
ALENDRONATE SODIUM 119 106
CYCLOBENZAPRINE HCL 110 69 R
ZOLPIDEM TARTRATE 102 75
LOSARTAN POTASSIUM 89 58
AMITRIPTYLINE HCL 89 46 R
FAMOTIDINE 85 43
ALLOPURINOL 84 84
HYDROCHLOROTHIAZIDE 81 63
POLYETHYLENE GLYCOL 3350 75 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 34
DIVALPROEX SODIUM 71 52
OXYBUTYNIN CHLORIDE 67 40
PROAIR HFA 65 45
TRICOR 63 25
TRIAMTERENE-HCTZ 61 47
HYDRALAZINE HCL 60 55
PRAVASTATIN SODIUM 59 46
FLUTICASONE PROPIONATE 59 44
NEXIUM 59 37
GLIPIZIDE ER 58 40
ADVAIR DISKUS 57 33
CARVEDILOL 57 47
PAROXETINE HCL 57 31
LANTUS SOLOSTAR 56 44
KLOR-CON M10 55 11
DIOVAN 54 41
CRESTOR 53 35
TAMSULOSIN HCL 53 43
RISPERIDONE 53 20
NAMENDA 53 50
MELOXICAM 52 37
SPIRIVA 51 44
CLOPIDOGREL 50 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.